First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

por Salamero, Olga, Montesinos, Pau, Willekens, Christophe, Pérez-Simón, José Antonio, Pigneux, Arnaud, Récher, Christian, Popat, Rakesh, Carpio, Cecilia, Molinero, César, Mascaró, Cristina, Vila, Joaquim, Arévalo, M. Isabel, Maes, Tamara, Buesa, Carlos, Bosch, Francesc, Somervaille, Tim C. P.
Publicado 2020

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Hematologic Patients: Experience at the Hospital Attending More Patients in Spain

por Cabirta, Alba, Izuzquiza, Macarena, Ruiz-Camps, Isabel, Valcarcel, David, Catala, Eva, Jimenez, M Moraima, Perez, Ana, Martin, Lucia, Rodriguez, Yva, Serna, Angel, Ruiz-Pace, Fiorella, Dienstmann, Rodrigo, Bobillo, Sabela, Carpio, Cecilia, Salamero, Olga, Abrisqueta, Pau, Bosch, Francesc
Publicado 2020

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

por Oñate, Guadalupe, Bataller, Alex, Garrido, Ana, Hoyos, Montserrat, Arnan, Montserrat, Vives, Susana, Coll, Rosa, Tormo, Mar, Sampol, Antònia, Escoda, Lourdes, Salamero, Olga, Garcia, Antoni, Bargay, Joan, Aljarilla, Alba, Nomdedeu, Josep F., Esteve, Jordi, Sierra, Jorge, Pratcorona, Marta
Publicado 2022

First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia

por Boyiadzis, Michael, Desai, Pinkal, Daskalakis, Nikki, Donnellan, William, Ferrante, Lucille, Goldberg, Jenna D., Grunwald, Michael R., Guttke, Christina, Li, Xiang, Perez‐Simon, Jose Antonio, Salamero, Olga, Tucker, Trevor, Xu, Xiaoying, Yang, Jay, Pemmaraju, Naveen, Alonso‐Dominguez, Juan Manuel
Publicado 2023

Vaccination Against Sars-Cov-2 Induces Robust Humoral Immune Response in Patients with Previous Hematologic Stem Cell Transplantation

por Roldan, Elisa, Del Carmen Jimenez, Moraima, Villacampa, Guillermo, Fernandez-Naval, Candela, Perez, Ana, Fox, Laura, Orti, Guillermo, Salamero, Olga, Barba, Pere, Campins, Magda, Esperalba, Juliana, Ruiz-Camps, Isabel, Crespo, Marta, Hernández-González, Manuel, Bosch, Francesc, Abrisqueta, Pau, Valcarcel, David
Publicado 2022

Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort

por Oñate, Guadalupe, Pratcorona, Marta, Garrido, Ana, Artigas-Baleri, Alicia, Bataller, Alex, Tormo, Mar, Arnan, Montserrat, Vives, Susana, Coll, Rosa, Salamero, Olga, Vall-Llovera, Ferran, Sampol, Antònia, Garcia, Antoni, Cervera, Marta, Avila, Sara Garcia, Bargay, Joan, Ortín, Xavier, Nomdedéu, Josep F., Esteve, Jordi, Sierra, Jorge
Publicado 2023

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

por Kayser, Sabine, Rahmé, Ramy, Martínez-Cuadrón, David, Ghiaur, Gabriel, Thomas, Xavier, Sobas, Marta, Guerci-Bresler, Agnes, Garrido, Ana, Pigneux, Arnaud, Gil, Cristina, Raffoux, Emmanuel, Tormo, Mar, Vey, Norbert, de la Serna, Javier, Salamero, Olga, Lengfelder, Eva, Levis, Mark J., Fenaux, Pierre, Sanz, Miguel A., Platzbecker, Uwe, Schlenk, Richard F., Adès, Lionel, Montesinos, Pau
Publicado 2020

Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

por Kayser, Sabine, Rahmé, Ramy, Martínez-Cuadrón, David, Ghiaur, Gabriel, Thomas, Xavier, Sobas, Marta, Guerci-Bresler, Agnes, Garrido, Ana, Pigneux, Arnaud, Gil, Cristina, Raffoux, Emmanuel, Tormo, Mar, Vey, Norbert, de la Serna, Javier, Salamero, Olga, Lengfelder, Eva, Levis, Mark J., Fenaux, Pierre, Sanz, Miguel A., Platzbecker, Uwe, Schlenk, Richard F., Adès, Lionel, Montesinos, Pau
Publicado 2021

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

por de Botton, Stéphane, Montesinos, Pau, Schuh, Andre C., Papayannidis, Cristina, Vyas, Paresh, Wei, Andrew H., Ommen, Hans, Semochkin, Sergey, Kim, Hee-Je, Larson, Richard A., Koprivnikar, Jaime, Frankfurt, Olga, Thol, Felicitas, Chromik, Jörg, Byrne, Jenny, Pigneux, Arnaud, Thomas, Xavier, Salamero, Olga, Vidriales, Maria Belen, Doronin, Vadim, Döhner, Hartmut, Fathi, Amir T., Laille, Eric, Yu, Xin, Hasan, Maroof, Martin-Regueira, Patricia, DiNardo, Courtney D.
Publicado 2023

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

por Ayala, Rosa, Rapado, Inmaculada, Onecha, Esther, Martínez-Cuadrón, David, Carreño-Tarragona, Gonzalo, Bergua, Juan Miguel, Vives, Susana, Algarra, Jesus Lorenzo, Tormo, Mar, Martinez, Pilar, Serrano, Josefina, Herrera, Pilar, Ramos, Fernando, Salamero, Olga, Lavilla, Esperanza, Gil, Cristina, López Lorenzo, Jose Luis, Vidriales, María Belén, Labrador, Jorge, Falantes, José Francisco, Sayas, María José, Paiva, Bruno, Barragán, Eva, Prosper, Felipe, Sanz, Miguel Ángel, Martínez-López, Joaquín, Montesinos, Pau
Publicado 2021

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

por Döhner, Hartmut, Symeonidis, Argiris, Deeren, Dries, Demeter, Judit, Sanz, Miguel A., Anagnostopoulos, Achilles, Esteve, Jordi, Fiedler, Walter, Porkka, Kimmo, Kim, Hee-Je, Lee, Je-Hwan, Usuki, Kensuke, D'Ardia, Stefano, Won Jung, Chul, Salamero, Olga, Horst, Heinz-August, Recher, Christian, Rousselot, Philippe, Sandhu, Irwindeep, Theunissen, Koen, Thol, Felicitas, Döhner, Konstanze, Teleanu, Veronica, DeAngelo, Daniel J., Naoe, Tomoki, Sekeres, Mikkael A., Belsack, Valerie, Ge, Miaomiao, Taube, Tillmann, Ottmann, Oliver G.
Publicado 2021

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

por Bataller, Alex, Garrido, Ana, Guijarro, Francesca, Oñate, Guadalupe, Diaz-Beyá, Marina, Arnan, Montserrat, Tormo, Mar, Vives, Susana, de Llano, María Paz Queipo, Coll, Rosa, Gallardo, David, Vall-Llovera, Ferran, Escoda, Lourdes, Garcia-Guiñon, Antonio, Salamero, Olga, Sampol, Antònia, Merchan, Brayan M., Bargay, Joan, Castaño-Díez, Sandra, Esteban, Daniel, Oliver-Caldés, Aina, Rivero, Andrea, Mozas, Pablo, López-Guerra, Mònica, Pratcorona, Marta, Zamora, Lurdes, Costa, Dolors, Rozman, Maria, Nomdedéu, Josep F., Colomer, Dolors, Brunet, Salut, Sierra, Jorge, Esteve,, Jordi
Publicado 2022

S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOS...

por Montesinos, Pau, Rodríguez-Veiga, Rebeca, Bergua Burgues, Juan Miguel, Algarra, Lorenzo, Botella, Carmen, Josè Antonio, Perez Simon, Bernal, Teresa, Tormo, Mar, Robles, Maria Calbacho, Salamero, Olga, Serrano, Josefina, Noriega, Victor, López-López, Juan Antonio, Polo, Susana Vives, Colorado, Mercedes, Lorenzo, Jose Luis Lopez, Vidriales, María Belén, Boyero, Raimundo Garcia, Olave, Mayte, Herrera-Puente, Pilar, Arce, Olga, Garcia, Manuel Barrios, Jose Sayas Lloris, Maria, Polo, Marta, Isabel Gomez Roncero, Maria, Barragan, Eva, Ayala Diaz, Rosa, Carmen Chillon, Maria, Jose Calasanz, Maria, Boluda, Blanca, Martinez-Cuadrón, David, Labrador, Jorge
Publicado 2023

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLASMS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: THE PETHEMA-PALG EXPERIENCE.

por Sobas, Marta, Knopinska-Posluszny, Wanda, Piątkowska-Jakubas, Beata, Ossenkoppele, Gert, García-Álvarez, Flor, Elena Amutio Díez, María, Caballero, Mar, Martinez-Cuadrón, David, Aguiar, Eliana, Gonzalez Campos, Jose, Garrido Diaz, Ana, Algarra, Lorenzo, Salamero, Olga, de la Serna, Javier, Jose Sayas Lloris, Maria, Mateo Perez Encinas, Manuel, Vives Polo, Susana, Gonzalez DE LA Calle, Veronica, Labrador, Jorge, Inés Prado, Ana, Celebrin, Lucía, Mayer, Jiri, Luiza O P Neto Vasconcelos Esteves, Graca, de Laiglesia, Almudena, Miguel Bergua Burgues, Juan, Luz Amigo, Maria, Rodriguez Medina, Carlos, Polo, Marta, Pluta, Agnieszka, Cichocka, Edyta, Skarupski, Marek, A Sanz, Miguel, Montesinos, Pau
Publicado 2023

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

por Bernal, Teresa, Moreno, Ainhoa Fernández, de LaIglesia, Almudena, Benavente, Celina, García‐Noblejas, Ana, Belmonte, Daniel García, Riaza, Rosalía, Salamero, Olga, Foncillas, Maria Angeles, Roldán, Alicia, Concepción, Víctor Noriega, González, Laura Llorente, Bergua Burgués, Juan Miguel, Lorente de Uña, Soraya, Rodríguez‐Macías, Gabriela, de la Fuente Burguera, Adolfo, García Pérez, Maria José, López‐Lorenzo, Jose Luis, Martínez, Pilar, Aláez, Concepción, Callejas, Marta, Martínez‐Chamorro, Carmen, Roca, José Rifón, Barciela, Lourdes Amador, Mena Durán, Armando V., Gómez Correcha, Karoll, Lavilla Rubira, Esperanza, Amigo, María Luz, Vall‐llovera, Ferran, Garrido, Ana, García‐Fortes, María, de Miguel Llorente, Dunia, Leonardo, Anastasia Aules, Cervero, Carlos, Jordá, Rosa Coll, Pérez‐Encinas, Manuel M., Zarzuela, Marta Polo, Figuera, Angela, Rad, Guillermo, Martínez‐Cuadrón, David, Montesinos, Pau
Publicado 2023